Martine Zimmermann insider trades

Open-market stock purchases and sales by Martine Zimmermann, Director at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since Sep 22, 2023.

Recent trades

DateStockTradeValue
Sep 22, 2026LGND Ligand Pharmaceuticals IncSold (not open market)$34.3K
Sep 10, 2026LGND Ligand Pharmaceuticals IncSold$342K
Sep 8, 2026CADL Candel Therapeutics, IncBought (not open market)—
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jun 5, 2026LGND Ligand Pharmaceuticals IncSold (not open market)$43.1K
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 1 sale, last Sep 22, 2026
  • CADL Candel Therapeutics, Inc: other filings, last Sep 8, 2026

Get free alerts when Martine Zimmermann files a new trade →